Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...
Dr. Brianne Borden is a trumpet soloist, clinician, educator, and author. She is Assistant Professor of Trumpet at the University of Delaware. Prior to UD, Borden taught at the Crane School of Music ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results